Skip to main content

Table 2 Clinical trials using nanoparticles with melanoma patients

From: Magnetic nanoparticles in theranostics of malignant melanoma

Clinical trial no.

Phase

Patients

Study design

Status

Purpose

Refs

NCT00626405

II

Unresectable stage IV melanoma

Bevacizumab + Temozolomide vs Bevacizumab + paclitaxel albumin-stabilized nanoparticle formulation + carboplatin

Completed

Treatment

[100]

NCT00081042

II

Unresectable stage IV melanoma

Paclitaxel albumin-stabilized nanoparticle formulation; previously chemotherapy vs chemotherapy-naive

Completed

Treatment

[101]

NCT00738361

II

Unresectable metastatic uveal melanoma

Paclitaxel albumin-stabilized nanoparticle formulation; single group

Completed

Treatment

 

NCT00404235

II

Unresectable stage IV melanoma

Paclitaxel albumin-stabilized nanoparticle formulation; chemotherapy-naïve; single group

Completed

Treatment

[100]

NCT02158520

II

Unresectable stage IV melanoma

Bevacizumab + paclitaxel albumin-stabilized nanoparticle formulation vs ipilimumab

Completed

Treatment

[103]

NCT01300533

I

Advanced or metastatic cancer including melanoma

BIND-014: targeted docetaxel polymeric nanoparticle; single group

Completed

Treatment

[104]

NCT02668536

I

Melanoma and UV ray damaged skin

Standard sunscreen vs sunscreen based on bioadhesive nanoparticles

Completed

Prevention

[105]

NCT04899908

II

Cancer with brain metastasis including melanoma

Stereotactic radiation with vs without AGuIX gadolinium-based nanoparticles

Recruiting

Treatment

 

NCT03739931

I

Advanced malignancies including melanoma

Lipid nanoparticle encapsulating mRNAs with vs without durvalumab

Recruiting

Treatment

 

NCT02106598

II

Head and neck melanoma

Silica nanoparticles with fluorescent cRGDY-PEG-Cy5.5-C dots for real-time image-guided intraoperative mapping of nodal metastases

Recruiting

Diagnostic

 
  1. Completed and recruiting clinical studies currently listed in the NIH database of the U.S. National Library of Medicine(https://clinicaltrials.gov)